2. India's leading manufacturer, supplier and exporter of aroma and fragrance chemicals.
#Privy Speciality Chemical - Superior Business Model ?
A Detailed Thread 🧵🧵
Like & Retweet for Max Reach !!
Price : ₹ 1986 🌹🥀
2. India's leading manufacturer, supplier and exporter of aroma and fragrance chemicals.
1. Aroma chemicals which form the building blocks of the F & F industry is a size of about USD 5.5bn. This multi-billion-dollar industry impacts daily life for consumers worldwide, often on multiple fronts: From the toothpaste we use, to the coffee, tea,
2. The industry value chain begins from the petrochemical manufacturers and ends with the FMCG industries.
1. Privi manufactures aroma chemicals which are used by the Fragrance and flavours industry to make different formulations having application in the FMCG industry.
1. In early times, extracts of flowers were used to make fragrances, however in modern times with scarcity of flora and fauna, the aroma industry is dependent on petrochemicals and pinene for their raw material requirement.
1. From the petrochemicals value chain we derive benzene, toluene, xylene, phenols aldehydes etc and other types of chemicals.These chemicals go hand in hand with essential oils or isolates and under
Nitro musk was widely used during the 20th century but is now prohibited because of certain neurotoxicity and their phototoxicity.
The pinene molecule is derived from two sources i.e. GTO & CST. This pinene molecule has isomers composition of alpha pinene, beta pinene and di-pentenes, all of these belong to the broad family of terpenes.
Margin hierarchy: Specialty > Citral > Pinene > Phenols.
Privi has 3 manufacturing units with a total production capacity of - 32,500 TPA spread across Amber fleur, Acetates, Dihydromyrcenol, Ionones, Nitriles, Sandal wood derivatives and Specialty chemicals.
Conventional technology derived pinene from GTO. GTO is derived from pine trees and is an expensive raw material. Crude sulphate turpentine is comparatively cheaper but due to high sulphur content and
Privi speciality developed in-house technology to derive pinene from CST giving them the competitive advantage over others.
The numbers translate the process innovation as the revenues improved post CST manufacturing along with expansion in margins.
Camphor: Camphor is used in pharmaceutical and industrial applications.
Asset Turnover of 2X with 3000 Cr revenue guidance in 3-3.5 years post capex. (Continued)
With CST processing technology and manufacturing value added products from waste is what determines the R&D efforts of privi specialty
More from Value Educator
Initially we had planned 3 part series on Pharma Sector but now we are adding one more part and making it 4 part series.
Part 1 : Introduction to pharma industry
Link : https://t.co/XZvGKjxo0C
Part 2: Drug discovery process with CRAMS, CDMO, CMO, CSM
Link : https://t.co/MPQm0OXUbL
Part 3 : Generic Drugs (ANDA)
Coming this Saturday at 11 AM
Part 4: Bio-similars
Like & Retweet to support us in the journey to educate investors !!
Part 1 : Introduction to pharma industry
Link : https://t.co/XZvGKjxo0C
Part 2: Drug discovery process with CRAMS, CDMO, CMO, CSM
Link : https://t.co/MPQm0OXUbL
Part 3 : Generic Drugs (ANDA)
Coming this Saturday at 11 AM
Part 4: Bio-similars
Like & Retweet to support us in the journey to educate investors !!
You May Also Like
1/“What would need to be true for you to….X”
Why is this the most powerful question you can ask when attempting to reach an agreement with another human being or organization?
A thread, co-written by @deanmbrody:
2/ First, “X” could be lots of things. Examples: What would need to be true for you to
- “Feel it's in our best interest for me to be CMO"
- “Feel that we’re in a good place as a company”
- “Feel that we’re on the same page”
- “Feel that we both got what we wanted from this deal
3/ Normally, we aren’t that direct. Example from startup/VC land:
Founders leave VC meetings thinking that every VC will invest, but they rarely do.
Worse over, the founders don’t know what they need to do in order to be fundable.
4/ So why should you ask the magic Q?
To get clarity.
You want to know where you stand, and what it takes to get what you want in a way that also gets them what they want.
It also holds them (mentally) accountable once the thing they need becomes true.
5/ Staying in the context of soliciting investors, the question is “what would need to be true for you to want to invest (or partner with us on this journey, etc)?”
Multiple responses to this question are likely to deliver a positive result.
Why is this the most powerful question you can ask when attempting to reach an agreement with another human being or organization?
A thread, co-written by @deanmbrody:
Next level tactic when closing a sale, candidate, or investment:
— Erik Torenberg (@eriktorenberg) February 27, 2018
Ask: \u201cWhat needs to be true for you to be all in?\u201d
You'll usually get an explicit answer that you might not get otherwise. It also holds them accountable once the thing they need becomes true.
2/ First, “X” could be lots of things. Examples: What would need to be true for you to
- “Feel it's in our best interest for me to be CMO"
- “Feel that we’re in a good place as a company”
- “Feel that we’re on the same page”
- “Feel that we both got what we wanted from this deal
3/ Normally, we aren’t that direct. Example from startup/VC land:
Founders leave VC meetings thinking that every VC will invest, but they rarely do.
Worse over, the founders don’t know what they need to do in order to be fundable.
4/ So why should you ask the magic Q?
To get clarity.
You want to know where you stand, and what it takes to get what you want in a way that also gets them what they want.
It also holds them (mentally) accountable once the thing they need becomes true.
5/ Staying in the context of soliciting investors, the question is “what would need to be true for you to want to invest (or partner with us on this journey, etc)?”
Multiple responses to this question are likely to deliver a positive result.